Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 80 results found. Search for [ phase 3 trials of Sputnik V india ]

Results 1 to 21 of 80
PTI
January 16, 2021
Speaking at the 25th Wharton India Economic Forum, he said the Indian pharma industry ensured the continuity of supplies


BusinessToday.In
January 16, 2021
Sputnik V vaccine phase 3: The Data and Safety Monitoring Board (DSMB) had reviewed the safety data from phase 2 trials of the vaccine and stated that there were no safety concerns attached to the jab earlier this week


BusinessToday.In
January 12, 2021
Among these vaccines are those developed by Zydus Cadila, Biological E and Gennova, along with Russia's Sputnik-V vaccine


BusinessToday.In
January 12, 2021
Stocks to watch today on January 12:  GAIL, Tata Motors, Dr Reddy, M&M, HUL, Force Motors, Sunteck Realty among others are the top stocks to watch out for in Tuesday's trading session


Manoj Sharma | Mudit Kapoor
January 7, 2021
Initial 30 crore vaccinations (60 crore doses) planned by the Centre would have cost Rs 13,200 crore. However, need for 66 crore doses raises the cost by Rs 1320 crore


Manoj Sharma
January 5, 2021
There was immense pressure on governments to develop a vaccine at the earliest due to the destruction COVID-19 pandemic was unleashing. This led to a race among pharma companies to be the first to develop a vaccine


BusinessToday.In
January 4, 2021
Coronavirus vaccine in India: Adar Poonawalla, CEO of Serum Institute of India that is manufacturing Covishield had said that the company is ready to roll out its vaccine in the coming weeks


Reuters
December 27, 2020
Coronavirus vaccine: Russia launched a voluntary vaccination programme with the Russia-made Sputnik V vaccine earlier in December, starting with the most vulnerable groups in Moscow


PTI
December 27, 2020
The vaccine development process by Bharat Biotech, Biological E Ltd and Aurobindo Pharma are currently in various stages, while Dr Reddy's and Hetero have tie ups for manufacturing the vaccine


BusinessToday.In
December 18, 2020
In India, RDIF has tied up with Dr Reddy's Laboratories for trials and regulatory approvals. Dr Reddy's recently began phase-2 and 3 clinical trials after getting requisite clearance


PTI
December 17, 2020
Alka Sharma, an adviser with the Department of Biotechnology said more than 100 participants from Afghanistan, Bhutan, Maldives, Mauritius, Nepal, Sri Lanka took part in this training programme


BusinessToday.In
December 14, 2020
Calculation was based on the analysis of data of volunteers who received both the first and second doses of the Sputnik V vaccine or placebo at the third and final control point of 78 confirmed cases in accordance with the Phase III clinical trials protocol


Anshula Raj
December 10, 2020
Both Pfizer and Moderna have admitted that taking their vaccines could result in side-effects similar to mild Covid symptoms such as muscle pain, chills and a headache


PTI
December 8, 2020
Over the last four days, the Indian arm of US pharmaceutical giant Pfizer, Pune-based Serum Institute of India and Hyderabad-based pharmaceutical firm Bharat Biotech have applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation


BusinessToday.In
December 8, 2020
Coronavirus vaccine update: The ministry also said that India has eight coronavirus vaccine candidates in the making. Out of the eight, two have applied for emergency use authorisation


BusinessToday.In
December 7, 2020
As per the Indian Council of Medical Research (ICMR), Serum Institute has manufactured four crore doses of the vaccine under the at-risk manufacturing and stockpiling licence obtained from the DCGI


BusinessToday.In
December 4, 2020
COVID-19 vaccine trial updates: AIIMS director Dr Randeep Guleria has pinned his hopes on the five coronavirus vaccine candidates which are in varying stages of trials across India


BusinessToday.In
December 3, 2020
However, VK Paul, who heads the National Task Force on COVID-19, had said in November that the arrival of the Pfizer vaccine in India might take months.


BusinessToday.In
December 2, 2020
The decision comes as Russia recorded 589 new deaths on a day; Russian Deputy Prime Minister Tatiana Golikova that large-scale vaccinations on voluntary basis will began across the country soon


Manoj Sharma
December 2, 2020
Pfizer and BioNTech vaccine: The UK has already ordered 40 million doses of the Pfizer vaccine to vaccinate its 20 million population, of which around 10 million doses will be available soon


PAGES 1 OF 4  1234